Mizuho Securities Cuts Price Target on Pacira Pharma (PCRX); Sights Conservatism

Go back to Mizuho Securities Cuts Price Target on Pacira Pharma (PCRX); Sights Conservatism

Pacira Pharma (PCRX) Tops Q1 EPS by 8c; EXPAREL Sales Rose 14%

May 2, 2016 8:57 AM EDT

Pacira Pharma (NASDAQ: PCRX) reported Q1 EPS of $0.15, $0.08 better than the analyst estimate of $0.07. Revenue for the quarter came in at $65.5 million versus the consensus estimate of $67.11 million.

EXPAREL net product revenues were $63.8 million in the first quarter of 2016, compared to $56.0 million in... More

Trading Radar for 5/2: AIG (AIG), Ferrari (RACE), Loews (L), On Deck Capital (ONDK), Tenet Healthcare (THC) Report

April 29, 2016 3:24 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

Boardwalk Pipeline Partners (NYSE: BWP) - consensus EPS $0.35
Broadsoft (Nasdaq: BSFT) - consensus EPS $0.26
CEVA, Inc. (Nasdaq: CEVA) - consensus EPS $0.16
CNA Financial (NYSE: CNA) - consensus EPS $0.63
Diamond Offshore Drilling (NYSE: DO) - consensus EPS $0.27
Education Realty Trust (NYSE: EDR) -... More